CPA
Copa Holdings, S.A.
CPA's outlook is improving, though it still trails on the overall score.
VRT
Vertiv Holdings Co
VRT has the edge over CPA overall, supported by stronger valuation and stronger modeled upside.
CPA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
CPA's revenue, profitability, cash flow and balance sheet are all currently healthy.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
CPA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.6x | $100 | -30% |
| Forward | 8.2x | $143 | — |
| Fair | 8.5x | $130 | -9.1% |
| Current | 9.4x | $143 | — |
| Expensive | 11x | $171 | +20% |
Historical ranges are pointers, not guarantees.
CPA's PE is in its fair range at 9.4x. If earnings grow as analysts expect, today's price would be 8.2x next year's earnings.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over CPA in the historical PE scenario, which offers more potential upside but is not a forecast.
CPA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CPA, with profitability improving. However, they disagree widely on these estimates.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
CPA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $17.32 | +14% |
| Q2 2026 | $15.22 | -1% |
| Q1 2026 | $17.16 | +17% |
| Q4 2025 | $16.28 | +12% |
| Q3 2025 | $16.09 | +4.9% |
| Q2 2025 | $15.38 | -7.1% |
| Q1 2025 | $14.65 | +3.8% |
| Q4 2024 | $14.56 | +12% |
| Q3 2024 | $15.34 | +47% |
CPA earned $15.22 per share over the past year, down 1% from the year before.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over CPA on earnings, with more consistent year-over-year improvement.
CPA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.1B | +26% |
| Q1 2026 | $1.1B | +17% |
| Q4 2025 | $962.9M | +9.6% |
| Q3 2025 | $913.1M | +6.8% |
| Q2 2025 | $842.6M | +2.8% |
| Q1 2025 | $899.2M | +0.6% |
| Q4 2024 | $878.6M | -3.7% |
| Q3 2024 | $854.7M | -1.5% |
CPA's revenue has grown year over year for six quarters in a row: $1.1B last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 8.7% | -12 points |
| Q1 2026 | 25% | +0.8 points |
| Q4 2025 | 22% | -0.7 points |
| Q3 2025 | 23% | +2.9 points |
| Q2 2025 | 21% | +1.5 points |
| Q1 2025 | 24% | -0.4 points |
| Q4 2024 | 23% | -0.3 points |
| Q3 2024 | 20% | -3.3 points |
CPA's operating margin was 8.7% last quarter, down 12 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over CPA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over CPA on profitability, with a higher operating margin.
CPA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$49.5M | +$62.2M |
| Q1 2026 | -$54.4M | -126% |
| Q4 2025 | $352.5M | +$641.2M |
| Q3 2025 | -$78M | -141% |
| Q2 2025 | -$111.7M | -141% |
| Q1 2025 | $205.5M | +2.2% |
| Q4 2024 | -$288.7M | +$231.3M |
| Q3 2024 | $188.6M | -45% |
CPA's free cash flow has turned positive again: $171M over the past year, against −$6M the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over CPA on cash flow, with more consistent year-over-year improvement.
CPA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.6x | Healthy |
| Q1 2025 | 1.6x | Healthy |
| Q4 2024 | 1.3x | Healthy |
| Q3 2024 | 1.4x | Healthy |
CPA's net debt is less than a year of its operating earnings (EBITDA), down from 1.6 years a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over CPA on leverage, with a lower net debt burden relative to earnings.
CPA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.9 | Neutral |
| Stochastic | 49.0 | Neutral |
CPA's weekly RSI is 58 (neutral) and its Stochastic is 49 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
CPA PE vs Industrials Sector
| Metric | CPA | Sector median | Relative |
|---|---|---|---|
| PE | 9.4x | 24x | 61% below |
| PE % | 62 | 58 | 4 pts above |
CPA has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
CPA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $134.9 | 5.9% above |
| 20 week MA | $136.5 | 4.6% above |
| 50 week MA | $132.3 | 7.9% above |
| 100 week MA | $118.8 | 20% above |
| 200 week MA | $107.8 | 33% above |
CPA has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
CPA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $107.5 | $74.9 | -30% |
| 2021 | $74.9 | $82.4 | +10% |
| 2022 | $82.4 | $84.6 | +2.6% |
| 2023 | $84.6 | $106.3 | +26% |
| 2024 | $106.3 | $87.6 | -18% |
| 2025 | $87.6 | $121.5 | +39% |
| 2026 YTD | $121.5 | $142.8 | +18% |
CPA has finished higher in four of the last six years. It's up 18% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over CPA on returns for 2026, with the stronger performance.